TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT00372996 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study NCT00372996 — Predictive Biomarker (PRD): Hormone receptor
Study NCT01908621 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT00629057 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study NCT02752152 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT03917043 — Predictive Biomarker (PRD): PTK2 mRNA
Genes: PTK2; FAK; FAK1
Study NCT03917043 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT03917043 — Predictive Biomarker (PRD): ROS1 mRNA
Genes: ROS1; MCF3; ROS
Study NCT04092244 — Predictive Biomarker (PRD): CTHRC1 mRNA
Genes: CTHRC1; UNQ762/PRO1550
Study NCT04090658 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT04474340 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04497311 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04376476 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT03796689 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00028925 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT04252937 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Adrenomedullin
Genes: ADM; AM
Study NCT00327145 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04015024 — Predictive Biomarker (PRD): FLT3 mRNA
Genes: FLT3; CD135; FLK2; STK1
Study NCT01824576 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02157896 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT02157896 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT00240734 — Surrogate Endpoint (SUR): Hemoglobin response rate
Study NCT01248897 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01977313 — Surrogate Endpoint (SUR): Serum testosterone
Study NCT03318263 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT03318263 — Predictive Biomarker (PRD): PIK3CA mRNA
Genes: PIK3CA
Study NCT03318263 — Predictive Biomarker (PRD): AKT1 mRNA
Genes: AKT1; PKB; RAC
Study NCT05022498 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01292668 — Predictive Biomarker (PRD): MAL mRNA
Genes: MAL
Study NCT02938468 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT03503994 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study NCT01685008 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT02835157 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT02553174 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT00338390 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT03893617 — Pharmacodynamic Biomarker (PDY): Gamma-Histone H2AX
Genes: H2AX; H2AFX
Study NCT00057941 — Predictive Biomarker (PRD): Hormone receptor
Study NCT03232177 — Surrogate Endpoint (SUR): Platelet count response
Study NCT03401281 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT03401281 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study NCT01487564 — Predictive Biomarker (PRD): UGT2B7 mRNA
Genes: UGT2B7; UGTB2B9
Study NCT00818298 — Safety Biomarker (SAF): DRD2
Study NCT00715676 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT01529554 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT01529554 — Predictive Biomarker (PRD): TNFRSF11B mRNA
Genes: TNFRSF11B; OCIF; OPG
Study NCT01529554 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Osteopontin
Genes: SPP1; BNSP; OPN; PSEC0156
Study NCT01529554 — Safety Biomarker (SAF): Cellular communication network factor 1
Genes: CCN1; CYR61; GIG1; IGFBP10
Study NCT01529554 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT01978964 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): Mucin-1
Genes: MUC1; PUM
Study NCT00845949 — Pharmacodynamic Biomarker (PDY): Stromal cell-derived factor 1
Genes: CXCL12; SDF1; SDF1A; SDF1B
Study NCT00845949 — Predictive Biomarker (PRD): CXCR4 mRNA
Genes: CXCR4
Study NCT05118607 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT04544033 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT01338090 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT00113061 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT01194908 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT00714233 — Predictive Biomarker (PRD): SHBG mRNA
Genes: SHBG
Study NCT04517526 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT03029338 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT02159820 — Predictive Biomarker (PRD): AADAC mRNA
Genes: AADAC; DAC
Study NCT02927769 — Predictive Biomarker (PRD): Lymphocyte activation antigen CD30
Genes: TNFRSF8; CD30; D1S166E
Study NCT00185809 — Predictive Biomarker (PRD): SLC5A5 mRNA
Genes: SLC5A5; NIS
Study NCT04610203 — Pharmacodynamic Biomarker (PDY): Gastric inhibitory polypeptide
Genes: GIP
Study NCT02997020 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study NCT03522428 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT03486496 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT03486496 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT00935805 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01919827 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT04525677 — Pharmacodynamic Biomarker (PDY): Blood coagulation
Study NCT00718458 — Predictive Biomarker (PRD): IGFALS mRNA
Genes: IGFALS; ALS
Study NCT02931630 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00001566 — Predictive Biomarker (PRD): APC mRNA
Genes: APC; DP2.5
Study NCT00001566 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT00016653 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study NCT03201146 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT03201146 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT00537641 — Predictive Biomarker (PRD): IGFALS mRNA
Genes: IGFALS; ALS
Study NCT04163588 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT04552405 — Predictive Biomarker (PRD): FAP mRNA
Genes: FAP
Study NCT02014610 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT01954043 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT04385251 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT03847168 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03937206 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT03937206 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT00957281 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT00915590 — Safety Biomarker (SAF): Interleukin 1
Study NCT01291862 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT04202705 — Predictive Biomarker (PRD): TPBG mRNA
Genes: TPBG; 5T4
Study NCT03179241 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study NCT01021501 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02284139 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT02284139 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02349555 — Surrogate Endpoint (SUR): Serum triglycerides
Study NCT01068704 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01068704 — Predictive Biomarker (PRD): Hormone receptor
Study NCT01050764 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT00833846 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT04568707 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT03483350 — Predictive Biomarker (PRD): NTS mRNA
Genes: NTS
Study NCT05316636 — Predictive Biomarker (PRD): TNFRSF11B mRNA
Genes: TNFRSF11B; OCIF; OPG
Study NCT03407222 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02521051 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT03614858 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT03614858 — Predictive Biomarker (PRD): CD22 mRNA
Genes: CD22; SIGLEC2
Study NCT01260662 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03367780 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT00214682 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT04595591 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04260035 — Predictive Biomarker (PRD): VIP mRNA
Genes: VIP
Study NCT02450058 — Predictive Biomarker (PRD): EFS mRNA
Genes: EFS; CASS3
Study NCT02349022 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT02646488 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04414046 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT02697708 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02697708 — Surrogate Endpoint (SUR): Serum potassium
Study NCT02789839 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT02340962 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT00021541 — Predictive Biomarker (PRD): NF1 mRNA
Genes: NF1
Study NCT00021541 — Predictive Biomarker (PRD): Nerve growth factor
Genes: NGF; NGFB
Study NCT00084097 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT00084097 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Immunoglobulin E
Study NCT03224624 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00225641 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study NCT01339312 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT03281317 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02117258 — Predictive Biomarker (PRD): GEM mRNA
Genes: GEM; KIR
Study NCT01816789 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study NCT02508870 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT00686309 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study NCT01556906 — Predictive Biomarker (PRD): MTTP mRNA
Genes: MTTP; MTP
Study NCT01556906 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT06282991 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT03155191 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT01657682 — Predictive Biomarker (PRD): FLT3 mRNA
Genes: FLT3; CD135; FLK2; STK1
Study NCT02829424 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04239287 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT01373047 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study NCT03610386 — Predictive Biomarker (PRD): TRPM8 mRNA
Genes: TRPM8; LTRPC6; TRPP8
Study NCT02495987 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study NCT04262245 — Predictive Biomarker (PRD): DNA repair endonuclease XPF
Genes: ERCC4; ERCC11; XPF
Study NCT04337658 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04337658 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT04337658 — Predictive Biomarker (PRD): Hormone receptor
Study NCT04337658 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT00695110 — Surrogate Endpoint (SUR): Serum testosterone
Study NCT00339417 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT02662569 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT04358627 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT01402128 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT01564901 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT01821157 — Predictive Biomarker (PRD): TNFRSF11B mRNA
Genes: TNFRSF11B; OCIF; OPG
Study NCT02791958 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT00201136 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03907605 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study NCT02726555 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT00450281 — Predictive Biomarker (PRD): GCNT2 mRNA
Genes: GCNT2; GCNT5; II; NACGT1
Study NCT00245986 — Predictive Biomarker (PRD): CYP2B6 mRNA
Genes: CYP2B6
Study NCT00245986 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT00245986 — Predictive Biomarker (PRD): CYP3A5 mRNA
Genes: CYP3A5
Study NCT00245986 — Predictive Biomarker (PRD): Multidrug resistance protein 1
Genes: ABCB1; MDR1; PGY1
Study NCT00286910 — Predictive Biomarker (PRD): NPHS2 mRNA
Genes: NPHS2
Study NCT00286910 — Predictive Biomarker (PRD): Arginine vasopressin
Genes: AVP; ARVP; VP
Study NCT01287533 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT00025389 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT03119662 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT01320397 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02664350 — Safety Biomarker (SAF): Cytochrome P450 2D6
Genes: CYP2D6; CYP2DL1
Study NCT01285843 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT00625339 — Monitoring Biomarker (MOI): HBV DNA
Study NCT01132261 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00288704 — Predictive Biomarker (PRD): NLRP3 mRNA
Genes: NLRP3; C1orf7; CIAS1; NALP3; PYPAF1
Study NCT00288704 — Safety Biomarker (SAF): Interleukin 1
Study NCT00325780 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT01468688 — Predictive Biomarker (PRD): PI3 mRNA
Genes: PI3; WAP3; WFDC14
Study NCT03674957 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03674957 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT03674957 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT03674957 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study NCT03674957 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT01586208 — Pharmacodynamic Biomarker (PDY): Valproic acid
Study NCT02283879 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT02511860 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01650311 — Predictive Biomarker (PRD): TPH1 mRNA
Genes: TPH1; TPH; TPRH; TRPH
Study NCT03672539 — Predictive Biomarker (PRD): Myeloid cell surface antigen CD33
Genes: CD33; SIGLEC3
Study NCT04123366 — Predictive Biomarker (PRD): Homologous recombination deficiency
Study NCT03709953 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT03439085 — Safety Biomarker (SAF): Interleukin 12
Study NCT01767909 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study NCT04374877 — Predictive Biomarker (PRD): EBI3 mRNA
Genes: EBI3; IL27B
Study NCT02535338 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT03242746 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study NCT02413008 — Predictive Biomarker (PRD): Hormone receptor
Study NCT02583802 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00743756 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00125190 — Predictive Biomarker (PRD): IGFALS mRNA
Genes: IGFALS; ALS
Study NCT01320722 — Pharmacodynamic Biomarker (PDY): Angiotensinogenase renin
Genes: REN
Study NCT01320722 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02015351 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT02015351 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT01344837 — Predictive Biomarker (PRD): SNCG mRNA
Genes: SNCG; BCSG1; PERSYN; PRSN
Study NCT00150683 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT02463019 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT03069469 — Predictive Biomarker (PRD): DCC mRNA
Genes: DCC; IGDCC1
Study NCT02691065 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT03068923 — Predictive Biomarker (PRD): PTS mRNA
Genes: PTS
Study NCT02028455 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT02953782 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT02054494 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT03702816 — Predictive Biomarker (PRD): TSPO mRNA
Genes: TSPO; BZRP; MBR
Study NCT01181830 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01223027 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT02641210 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02641210 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT02223169 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03082885 — Monitoring Biomarker (MOI): HBV DNA
Study NCT04079036 — Pharmacodynamic Biomarker (PDY): Transmembrane glycoprotein NMB
Genes: GPNMB; HGFIN; NMB; UNQ1725/PRO9925
Study NCT01066286 — Predictive Biomarker (PRD): KIT mRNA
Genes: KIT; SCFR
Study NCT01066286 — Predictive Biomarker (PRD): FLT3 mRNA
Genes: FLT3; CD135; FLK2; STK1
Study NCT03605719 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT00471263 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02694575 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT01361334 — Predictive Biomarker (PRD): PDGFRB mRNA
Genes: PDGFRB; PDGFR; PDGFR1
Study NCT01361334 — Predictive Biomarker (PRD): KIT mRNA
Genes: KIT; SCFR
Study NCT01480141 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT03924154 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT03789253 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study NCT03789253 — Predictive Biomarker (PRD): PC mRNA
Genes: PC
Study NCT03638297 — Predictive Biomarker (PRD): Microsatellite instability
Study NCT02309021 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04038645 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04038645 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04038645 — Safety Biomarker (SAF): Interleukin 1
Study NCT00752076 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01702415 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT06109532 — Surrogate Endpoint (SUR): Serum sodium
Study NCT00909168 — Predictive Biomarker (PRD): Myeloid cell surface antigen CD33
Genes: CD33; SIGLEC3
Study NCT00909168 — Predictive Biomarker (PRD): WT1 mRNA
Genes: WT1
Study NCT01223755 — Predictive Biomarker (PRD): SRL mRNA
Genes: SRL
Study NCT00413049 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00769496 — Pharmacodynamic Biomarker (PDY): Serum phosphate
Study NCT00024154 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05781529 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT03727360 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study NCT03958123 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02075840 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT03316443 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04264208 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT01091363 — Surrogate Endpoint (SUR): Exhaled carbon monoxide
Study NCT04000776 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT02970149 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study NCT01183884 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT02209857 — Predictive Biomarker (PRD): Hormone receptor
Study NCT03934320 — Predictive Biomarker (PRD): FH mRNA
Genes: FH
Study NCT04155424 — Pharmacodynamic Biomarker (PDY): Complement C5
Genes: C5; CPAMD4
Study NCT02213887 — Pharmacodynamic Biomarker (PDY): Valproic acid
Study NCT01937806 — Monitoring Biomarker (MOI): HBV DNA
Study NCT03670186 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT02018861 — Predictive Biomarker (PRD): JAK1 mRNA
Genes: JAK1; JAK1A; JAK1B
Study NCT02525263 — Predictive Biomarker (PRD): SRC mRNA
Genes: SRC; SRC1
Study NCT01861990 — Pharmacodynamic Biomarker (PDY): Valproic acid
Study NCT02571530 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00466531 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT01404910 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT01404910 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT02132624 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT02132624 — Predictive Biomarker (PRD): CD28 mRNA
Genes: CD28
Study NCT02136836 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05040139 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT00808249 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study NCT04130685 — Predictive Biomarker (PRD): GAD2 mRNA
Genes: GAD2; GAD65
Study NCT04130685 — Monitoring Biomarker (MOI): Cell-free DNA
Study NCT03190174 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT03258996 — Predictive Biomarker (PRD): VSIR mRNA
Genes: VSIR; C10orf54; SISP1; VISTA; PP2135; UNQ730/PRO1412